Disease Mongering Is Now Part of the Global Health Debate
article has not abstract
Vyšlo v časopise:
Disease Mongering Is Now Part of the Global Health Debate. PLoS Med 5(5): e106. doi:10.1371/journal.pmed.0050106
Kategorie:
Essay
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.0050106
Souhrn
article has not abstract
Zdroje
1. MoynihanRHenryD
2006
The fight against disease mongering: Generating knowledge for action.
PLoS Med
3
e191
doi:10.1371/journal.pmed.0030191
2. Consumers International
2007
Drugs, doctors and dinners: How drug companies influence health in the developing world.
Available: http://consint.live.poptech.coop/shared_asp_files/GFSR.asp?NodeID=97128. Accessed 28 March 2008
3. Association of the British Pharmaceutical Industry
2007
Media briefing: ‘Disease mongering’ and ‘lifestyle medicines.’.
Available: http://www.abpi.org.uk/press/media_briefings/pdfs/2007/DiseaseMongerLifestyleMeds.pdf. Accessed 28 March 2008
4. Public Library of Science
2006
A collection of articles on disease mongering in PLoS Medicine.
Available: http://collections.plos.org/plosmedicine/diseasemongering-2006.php. Accessed 28 March 2008
5. BBC News
2006 April 11
Drug firms ‘inventing diseases.’.
Available: http://news.bbc.co.uk/1/hi/health/4898488.stm. Accessed 28 March 2008
6. SampleI
2006 April 11
Drug firms accused of turning healthy people into patients. The Guardian.
Available: http://www.guardian.co.uk/medicine/story/0,,1751360,00.html. Accessed 28 March 2008
7. Wikipedia
2008
Disease mongering.
Available: http://en.wikipedia.org/wiki/Disease_mongering. Accessed 28 March 2008
8. Daneyal Mahmood Gallery
2007
Justine Cooper: Press and publications.
Available: http://www.daneyalmahmood.com/justinecooper_press.html. Accessed 28 March 2008
9. TieferL
2006
Female sexual dysfunction: A case study of disease mongering and activist resistance.
PLoS Med
3
e178
doi:10.1371/journal.pmed.0030178
10. HealyD
2006
The latest mania: Selling bipolar disorder.
PLoS Med
3
e185
doi:10.1371/journal.pmed.0030185
11. WoloshinSSchwartzLM
2006
Giving legs to restless legs: A case study of how the media helps make people sick.
PLoS Med
3
e170
doi:10.1371/journal.pmed.0030170
12. MoynihanR
2006
Scientists find new disease: Motivational deficiency disorder.
BMJ
332
745
13. [No authors listed]
2006
A new epidemic. A short video about motivational deficiency disorder, featuring Professor Leth Argos.
Available: http://www.youtube.com/watch?v=RoppJOtRLe4. Accessed 28 March 2008
14. Health News Review
2008
About Health News Review.
Available: http://www.healthnewsreview.org/about.php. Accessed 28 March 2008
15. SchwitzerG
2008
How do US journalists cover treatments, tests, products, and procedures? An evaluation of 500 stories.
PLoS Med
5
5
e95
doi:10.1371/journal.pmed.0050095
16. WhalenJ
2006 October 25
How Glaxo marketed a malady to sell a drug.
The Wall Street Journal
Available: http://online.wsj.com/article/SB116174246339602800.html. Accessed 28 March 2008
17. BerensonA
2008 January 14
Drug approved. Is disease real.
The New York Times
Available: http://www.nytimes.com/2008/01/14/health/14pain.html. Accessed 28 March 2008
18. [No authors listed]
2007
Interview with Dr. Harvey E. Bale, from the International Federation of Pharmaceutical Manufacturers. Recorded at the CI World Congress 2007.
Available: http://www.youtube.com/watch?v=ZP9hrk0Vuo4. Accessed 28 March 2008
19. WalshF
2006 April 28
Glaxo denies pushing lifestyle treatments.
The Guardian
Available: http://www.guardian.co.uk/science/2006/apr/28/business. Accessed 28 March 2008
20. University of Strathclyde
2007
Communication and conflict conference call for papers.
Available: http://gs.strath.ac.uk/content/view/303/130/. Accessed 28 March 2008
21. DoranEHenryDMoynihanR
2008
Pharmaceutical promotion: Productive or problematic? Australian Research Council Discovery Project DP0877633.
Available: http://www.arc.gov.au/pdf/DP08/DP08_NewcastleU.pdf. Accessed 28 March 2008
22. GagnonMALexchinJ
2008
The cost of pushing pills: A new estimate of pharmaceutical promotion expenditures in the United States.
PLoS Med
5
e1
doi:10.1371/journal.pmed.0050001
23. TanneJ
2007
FDA may allow drug and device companies to promote “off-label” uses.
BMJ
335
1229
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2008 Číslo 5
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
Najčítanejšie v tomto čísle
- Disease Mongering Is Now Part of the Global Health Debate
- Communicating the Results of Clinical Research to Participants: Attitudes, Practices, and Future Directions
- A User's Guide to the NINDS rt-PA Stroke Trial Database
- Expectations for Recovery Important in the Prognosis of Whiplash Injuries